Dr. Menon aims to solidify her standing as an authority in regulatory affairs with a focus on advocating for market and patient requirements to expedite the development of safe clinical drugs.
NAPERVILLE, IL, November 05, 2024 /24-7PressRelease/ -- Dr. Ambili Menon has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Menon is a respected professional in the field of scientific affairs and was appointed as the senior scientific affairs manager at bioMérieux in 2020. In this role, she ensures that drugs comply with Food and Drug Administration regulations and the U.S. Pharmacopeia before market release. She also guarantees that products are free of microorganisms and endotoxins and that they meet rigorous industry standards. Additionally, Dr. Menon guides customers through validation processes, supports the efficient and safe delivery of patient care through CAR T cell therapy and rapid drug distribution and collaborates closely with the FDA to advocate for industry needs.
Dr. Menon's career has been shaped by her diverse background in microbiology, immunology and cardiology. She is active in research and report and manuscript writing, and she contributes to comprehensive projects involving primary cell isolation and culturing human-induced pluripotent stem cells with hiPSCs BMMC mast cells activation. Notably, broad exposure to various scientific disciplines enables Dr. Menon to better appreciate patient needs and industry demands, contributing to a more holistic approach in her work.
Prior to progressing into her current position, Dr. Menon prospered as a postdoctoral research fellow at the University of Illinois Chicago College of Medicine from 2017 to 2020. Earlier in her career, Dr. Menon excelled as a research intern at Virginia Commonwealth University from 2007 to 2008 and an admission assistant at Enbee Education Center Private Limited from 2006 to 2007.
Dr. Menon's academic achievements include a bachelor's degree in zoology, animal biology, botany and chemistry from the Maharaja Sayajirao University of Baroda, which she finished in 2004 before pursuing graduate studies. She now proudly holds a master's degree in microbiology and immunology from the same institution, completed in 2006, and Dr. Menon earned a Doctor of Philosophy in biological science and chemistry from the Karlsruhe Institute of Technology in 2013, where she also thrived as a graduate teaching assistant from 2010 to 2013.
Comprehensive expertise across diverse platforms enables Dr. Menon to make meaningful contributions in areas such as pharmaceutical formulation, cellular immunology, immuno-oncology, cell signaling, molecular biology and immunotoxicity studies. She also participates in drug toxicity studies and excels at data analysis and interpretation. Additionally, Dr. Menon has obtained distinct industry credentials, including FDA GLP, 21CFR58 certification and pharmaceuticals FDA-cGMP training.
A dedication to scholarship further defines Dr. Menon's presence in her field, and her contributions to the scientific literature are notable. She authored "Ion Channel and Structural Remodeling in Obesity: Mediated Atrial Fibrillation," published in Circ Arrhythm Electrophysiol in 2020, and "Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs," which JAMA Cardiology published in 2019. Additionally, Dr. Menon contributed to "A Potent and Selective Small Molecule Inhibitor for the Lymphoid-Specific Tyrosine Phosphatase," published in the Journal of Medicinal Chemistry in 2013, among other articles.
Dr. Menon is an active member of several industry-related organizations including the American Heart Association and the Mastocytosis Society, and Dr. Menon is proud to have been associated with the European Mast Cell and Basophil Research Network-COST from 2010 to 2013 and SPP MASTZELL from 2010 to 2013.
Dr. Menon has received several accolades throughout her career including the NIH-T32 GRANT Postdoctoral Fellowship from the National Institute of Health in 2018 and the CCVR Young Investigator Award from UIC Center for Cardiovascular Research, also in 2018. Dr. Menon attributes her success to versatility and adaptability, as well as persistence in achieving her objectives.
Outside of her professional life, Dr. Menon is dedicated to civic engagement and volunteered at Shree Sayaji General Hospital from 2002 to 2006, a period in which she also helped coordinate food drives at St Basil's Church. She is a devoted mother to two children and enjoys spending quality time with her family. Looking toward the future, Dr. Menon aims to solidify her standing as an authority in regulatory affairs with a focus on advocating for market and patient requirements to expedite the development of safe clinical drugs. Additionally, Dr. Menon aspires to transition into consulting to further enhance patient care.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #